Announcements

Archive by year: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

Date	Title	Format
16/10/2000	ReGen Therapeutics strength organisation ahead of trial results and appoints Ernst and Young as nominated Adviser
30/07/2000	Interim Results for the six months to 30 June 2000
21/07/2000	Clinical Trials, Scientific and Manufacturing update
20/07/2000	AGM Statement
16/07/2000	ReGen Therapeutics is developing a therapy for Alzheimer's disease based on Colostrinin
16/07/2000	Key Financials
23/03/2000	ReGen Therapeitics Plc public offer oversubscribed ten times. AIM Dealings start at 8AM, 24 th March
15/03/2000	ReGen Therapeutics Plc plan AIM debut on 24 March 2000
24/02/2000	Regen Therapeutics Plc complete £4.25 million placing, Public offer opens to raise £750,000 prior to move to alternative investment market (AIM)
03/02/2000	Managing Director, Joins ReGen Therapeutics from Medeva ahead of AIM Flotation
11/01/2000	Board Appointment for ReGen Therapeutics Plc

If you are unable to view the PDF documents you may need to download the free Adobe Reader